Work and productivity loss related to herpes zoster

Journal of Medical Economics

Volumn 14, Issue 5, 2011, Pages 639-645

  Singhal, Puneet K ^a   Makin, Charles ^b,c   Pellissier, James ^a   Sy, Lina ^a,d   White, Ron ^a   Saddier, Patricia ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b IQVIA   (United States)

^c HEALTHCORE INC   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

Herpes zoster; Productivity loss; Shingles; Varicella zoster virus; Work loss

Indexed keywords

VARICELLA ZOSTER VACCINE;

ABSENTEEISM; ADULT; ARTICLE; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEALTH CARE PLANNING; HEALTH INSURANCE; HERPES ZOSTER; HOUSEHOLD; HUMAN; INFORMATION SERVICE; MAJOR CLINICAL STUDY; MALE; PRODUCTIVITY; SHOPPING; SOCIAL BEHAVIOR; WORK;

FEMALE; HEALTH SURVEYS; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; SICK LEAVE; UNITED STATES;

EID: 80052704971     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2011.607482     Document Type: Article

References (22)

1. Cohen JI, Brunell PA, Straus SE, et al. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999;130:922-32
2. Choo PW, Donahue JG, Manson JE, et al. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706-12
3. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005;352:2266-7
4. Insinga R, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748-53
5. Yawn B, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9
6. Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988;85(Suppl 2A):84-8
7. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989;102:93-5
8. McKendrick MW, McGill JI, White JE, et al. Oral acyclovir in acute herpes zoster. Br Med J 1986;293:1529-32
9. Johnson R, McElhaney J, Pedalino B, et al. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis 2007;11: S42-S7
10. Gnann J, Whitley RJ. Herpes zoster. N Engl J Med 2002;347:340-6
11. Schmader K. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350-4
12. Dworkin R, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003;36:877-82
13. Katz J, Cooper EM, Walther RR, et al. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004;39:342-8
14. Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011;86:88-93
15. Schmader K, Sloane R, Pieper C, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007;23:490-6
16. Mauskopf J, Austin R, Dix L, et al. The Nottingham Health Profile as a measure of quality of life in zoster patients: Convergent and discriminant validity. Qual Life Res 1994;3:431-5
17. Oster G, Harding G, Dukes E, et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: Results from a population-based survey. J Pain 2005;6:356-63
18. Lydick E, Epstein RS, Himmelberger D, et al. Herpes zoster and quality of life: A self-limited disease with severe impact. Neurology 1995;45:52-3
19. Insinga R, Itzler RF, Pellissier JM. Acute/subacute herpes zoster; healthcare resource utilsation and costs in a group of US health plans. Pharmacoeconomics 2007;25:155-69
20. White R, Lenhart G, Singhal PK, et al. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. PharmacoEconomics 2009;27:781-92
21. Employment status of the civilian noninstitutional population by age, sex, and race. United States Bureau of Labor Statistics, 2010. Available at: Http://www.bls.gov/cps/cpsaat3.pdf, accessed July 19, 2011
22. Scott F, Johnson RW, Leedham-Green M, et al. The burden of herpes zoster: A prospective population based study. Vaccine 2006;24:1308-14